Nu Skin and the short-sellers

“Has anybody seen our stock price lately? How high did we trade today? Anybody know?”

Truman Hunt, the impeccably groomed CEO of Nu Skin Enterprises NUS , a multilevel-marketing merchant of skin creams and nutritional products, was playing the tease. Spotlighted at center stage in the Utah Jazz’s Salt Lake City arena in late October a year ago, Hunt was evangelizing to 13,000 rapt distributors at Nu Skin’s biennial convention.

Everything was clicking for the company. Revenue and profits were soaring, thanks to what Nu Skin calls a “revolutionary” new “super-class” of anti-aging products it claims can arrest the ravages of time. The company’s chief scientific officer had gone so far as to proclaim them a “fountain of youth.”

Even Nu Skin’s stock, which had traded below its 1996 IPO price for nearly its entire existence, had finally taken off, rising more than 500% in less than three years. “Today we traded over $50!” Hunt exulted. Holding up a hand to hush the roaring crowd, he added, “Now, don’t get too used to that number because we’re going to be there very briefly on our road to $150!”

It was an extraordinary bit of hype, and hubris, from a CEO. And as moments of hubris sometimes are, it was followed by a series of events — alternately ominous and absurd — that have quickly taken Nu Skin from a roaring business success on a sharply upward trajectory to a company whose future looks considerably murkier.

MORE: Avon — the rise and fall of a beauty icon

The threat was easy to laugh off initially because it arrived in the chiseled forms of two angry former trophy husbands of Nu Skin co-founder Sandie Tillotson, 56. One is an ex-stripper with the stage name Dirty Dalton, who favored a 20-foot bullwhip as his principal accouterment; the other, a 6-foot-7 Dutch model, B-movie actor, and Arnold Schwarzenegger impersonator. Both men are promoting scathing memoirs, alleging unsavory behavior by Tillotson and the company. Tillotson resigned from Nu Skin’s board in May but remains a senior vice president. She has fought back ferociously, attempting to have one ex thrown in jail and smacking the other with a $60 million lawsuit.

All of that would have been just a mortifying sideshow were the B-movie actor not in league with a band of investors betting on the decline of Nu Skin’s stock. For months now, short-sellers have been circling, casting a harsh spotlight on the company’s practices and product claims, which have landed it in trouble before. Company shares have slipped from a 12-month high of $62 and settled near $44.